132 related articles for article (PubMed ID: 37292314)
1. Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer.
Oike T; Osu N; Yoshimoto Y; Obinata H; Yoshikawa K; Harris CC; Ohno T
Heliyon; 2023 Jun; 9(6):e16684. PubMed ID: 37292314
[TBL] [Abstract][Full Text] [Related]
2. Improved detection and precise relative quantification of the urinary cancer metabolite biomarkers - Creatine riboside, creatinine riboside, creatine and creatinine by UPLC-ESI-MS/MS: Application to the NCI-Maryland cohort population controls and lung cancer cases.
Patel DP; Pauly GT; Tada T; Parker AL; Toulabi L; Kanke Y; Oike T; Krausz KW; Gonzalez FJ; Harris CC
J Pharm Biomed Anal; 2020 Nov; 191():113596. PubMed ID: 32937240
[TBL] [Abstract][Full Text] [Related]
3. Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.
Parker AL; Toulabi L; Oike T; Kanke Y; Patel D; Tada T; Taylor S; Beck JA; Bowman E; Reyzer ML; Butcher D; Kuhn S; Pauly GT; Krausz KW; Gonzalez FJ; Hussain SP; Ambs S; Ryan BM; Wang XW; Harris CC
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35838048
[TBL] [Abstract][Full Text] [Related]
4. Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
Patel D; Thompson MD; Manna SK; Krausz KW; Zhang L; Nilubol N; Gonzalez FJ; Kebebew E
Clin Cancer Res; 2017 Sep; 23(17):5302-5310. PubMed ID: 28450405
[No Abstract] [Full Text] [Related]
5. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.
Mathé EA; Patterson AD; Haznadar M; Manna SK; Krausz KW; Bowman ED; Shields PG; Idle JR; Smith PB; Anami K; Kazandjian DG; Hatzakis E; Gonzalez FJ; Harris CC
Cancer Res; 2014 Jun; 74(12):3259-70. PubMed ID: 24736543
[TBL] [Abstract][Full Text] [Related]
6. LC/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics.
Khan I; Nam M; Kwon M; Seo SS; Jung S; Han JS; Hwang GS; Kim MK
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974861
[TBL] [Abstract][Full Text] [Related]
7. Regulators of cell division in plant tissues : XXV. Metabolism of zeatin by lupin seedlings.
Parker CW; Letham DS; Gollnow BI; Summons RE; Duke CC; Macleod JK
Planta; 1978 Jan; 142(3):239-51. PubMed ID: 24408185
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.
Zhao H; Heimberger AB; Lu Z; Wu X; Hodges TR; Song R; Shen J
Oncotarget; 2016 Apr; 7(15):20486-95. PubMed ID: 26967252
[TBL] [Abstract][Full Text] [Related]
9. Cytokinin Biochemistry in Relation to Leaf Senescence: IV. Cytokinin Metabolism in Soybean Explants.
Singh S; Letham DS; Jameson PE; Zhang R; Parker CW; Bandenoch-Jones J; Noodén LD
Plant Physiol; 1988 Nov; 88(3):788-94. PubMed ID: 16666385
[TBL] [Abstract][Full Text] [Related]
10. A HPLC method for simultaneous determination of 5-aminoimidazole-4-carboxamide riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in tumor-bearing nude mice plasma and its application to pharmacokinetics study.
Cheng X; Guo L; Li Z; Li L; Zhou T; Lu W
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():64-70. PubMed ID: 23340307
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy of the motor cortex in cervical myelopathy.
Kowalczyk I; Duggal N; Bartha R
Brain; 2012 Feb; 135(Pt 2):461-8. PubMed ID: 22180462
[TBL] [Abstract][Full Text] [Related]
12. Stable isotope dilution microquantification of creatine metabolites in plasma, whole blood and dried blood spots for pharmacological studies in mouse models of creatine deficiency.
Tran C; Yazdanpanah M; Kyriakopoulou L; Levandovskiy V; Zahid H; Naufer A; Isbrandt D; Schulze A
Clin Chim Acta; 2014 Sep; 436():160-8. PubMed ID: 24877651
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
[TBL] [Abstract][Full Text] [Related]
14. Identification of major metabolites in rat urine and plasma of N(6) -(4-hydroxybenzyl) adenine riboside by LC/MS/MS.
Lei Y; Wang L; Cheng M; Xiao H
Biomed Chromatogr; 2011 Mar; 25(3):344-52. PubMed ID: 21110386
[TBL] [Abstract][Full Text] [Related]
15. Cytokinin metabolism in Narcissus bulbs: chilling promotes acetylation of zeatin riboside.
Letham DS; Smith NG; Willcocks DA
Funct Plant Biol; 2003 Jul; 30(5):525-532. PubMed ID: 32689037
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance.
Kourtzidis IA; Dolopikou CF; Tsiftsis AN; Margaritelis NV; Theodorou AA; Zervos IA; Tsantarliotou MP; Veskoukis AS; Vrabas IS; Paschalis V; Kyparos A; Nikolaidis MG
Exp Physiol; 2018 Oct; 103(10):1357-1366. PubMed ID: 30007015
[TBL] [Abstract][Full Text] [Related]
17. Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer.
Lv A; Tu Z; Huang Y; Lu W; Xie B
Oncol Lett; 2021 Jan; 21(1):54. PubMed ID: 33281965
[TBL] [Abstract][Full Text] [Related]
18. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?
Synesiou E; Fairbanks LD; Simmonds HA; Slominska EM; Smolenski RT; Carrey EA
Toxins (Basel); 2011 Jun; 3(6):520-37. PubMed ID: 22069723
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profiling identifies hair as a robust biological sample for identifying women with cervical cancer.
Ran R; Zhong X; Yang Y; Tang X; Shi M; Jiang X; Lin A; Gan X; Yu T; Hu L; Dong X; Han TL
Med Oncol; 2023 Jan; 40(2):75. PubMed ID: 36609777
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
